Antiepileptic Activity of Indian Filbert Fruit Extract in Experimental Animal Models

Jennifer Fernandes *

Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Mangaluru, 575018, Karnataka, India.

S. Anusha

Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Mangaluru, 575018, Karnataka, India.

K. Vijay Bhaskar

Department of Pharmaceutical Chemistry, Manipal College of Pharmacy, Manipal Academy of Higher Education, Manipal, 576104,Karnataka, India.

*Author to whom correspondence should be addressed.


Abstract

Aim: To screen the antiepileptic activity of ethanolic fruit extract of Indian filbert.

Methodology: The cleaned, dried and powdered fruits of Indian filbert were subjected to extraction.Preliminary Phytochemical studies were carried out for the presence secondary metabolites.Acute toxicity and anticonvulsant effect on maximal electroshock induced seizures and metrazol (pentylenetetrazole) induced seizures carried out in experimental animals.

Results: Preliminary phytochemical studies showed the presence of steroids, triterpenoids, flavonoids, carbohydrates. Acute toxicity of ethanolic extract of fruits were found to be safe up to 2000 mg/kg body weight Ethanolic extract of Indian (100,200 and 400 mg/kg) significantly reduced the duration of seizures induced by maximal electroshock (MES) as well as protected animals from metrazol induced tonic seizures and the results were found to be significant (P=0.05) when compared to control

Conclusions: The presence of triterpenoids, steroids and flavonoid might be responsible for the antiepileptic activity of the fruit extract of Indian filbert.

Keywords: Indian filbert, antiepileptic activity, Sapindaceae, metrozol, maximal electroshock, pentylene tetrazole, phenytoin


How to Cite

Fernandes, Jennifer, S. Anusha, and K. Vijay Bhaskar. 2022. “Antiepileptic Activity of Indian Filbert Fruit Extract in Experimental Animal Models”. Journal of Pharmaceutical Research International 34 (28B):7-13. https://doi.org/10.9734/jpri/2022/v34i28B36029.

Downloads

Download data is not yet available.